Magellan Stem Cells
Best Stem Cell Research & Manufacturing Company 2026
Magellan is concentrating on seeking approval/registration re the treatment of osteoarthritis with allogeneic mesenchymal stem cells. Phase I and Phase II clinical trials have been completed - and a Phase III clinical trial is planned for commencement in early 2027. The stem cells are being cultured in Magellan's licensed GMP facility. Magellan has IP based upon the genetics of 'optimum 'cells' re the treatment of osteoarthritis.
Magellan has international IP based upon the genetics of the
Visit Site